Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identifying multimodal signatures underlying the somatic comorbidity of psychosis: the COMMITMENT roadmap.
Schwarz E, Alnæs D, Andreassen OA, Cao H, Chen J, Degenhardt F, Doncevic D, Dwyer D, Eils R, Erdmann J, Herrmann C, Hofmann-Apitius M, Kaufmann T, Koutsouleris N, Kodamullil AT, Khuntia A, Mucha S, Nöthen MM, Paul R, Pedersen ML, Quintero A, Schunkert H, Sharma A, Tost H, Westlye LT, Zhang Y, Meyer-Lindenberg A. Schwarz E, et al. Among authors: doncevic d. Mol Psychiatry. 2021 Mar;26(3):722-724. doi: 10.1038/s41380-020-00915-z. Epub 2020 Oct 15. Mol Psychiatry. 2021. PMID: 33060817 Free PMC article. No abstract available.
Super enhancers define regulatory subtypes and cell identity in neuroblastoma.
Gartlgruber M, Sharma AK, Quintero A, Dreidax D, Jansky S, Park YG, Kreth S, Meder J, Doncevic D, Saary P, Toprak UH, Ishaque N, Afanasyeva E, Wecht E, Koster J, Versteeg R, Grünewald TGP, Jones DTW, Pfister SM, Henrich KO, van Nes J, Herrmann C, Westermann F. Gartlgruber M, et al. Among authors: doncevic d. Nat Cancer. 2021 Jan;2(1):114-128. doi: 10.1038/s43018-020-00145-w. Epub 2020 Dec 7. Nat Cancer. 2021. PMID: 35121888
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signaling.
Würth R, Donato E, Michel LL, Saini M, Becker L, Cheytan T, Doncevic D, Messmer T, Gutjahr E, Weber R, Klein C, Alborzinia H, Yildiz U, Vogel V, Hlevnjak M, Kozyulina P, Neuberth SJ, Schwerd-Kleine P, Jakab S, Pfarr N, Angeles AK, Laut AK, Karpova D, Falcone M, Hardt O, Theek B, Wagner CV, Becker M, Wagner S, Haselmayr M, Schmitt A, Müller-Tidow C, Riethdorf S, Pantel K, Zapatka M, Sültmann H, Herrmann C, Thewes V, Lichter P, Schneeweiss A, Sprick MR, Trumpp A. Würth R, et al. Among authors: doncevic d. Nat Cancer. 2025 Jan 3. doi: 10.1038/s43018-024-00882-2. Online ahead of print. Nat Cancer. 2025. PMID: 39753722